Amgen is expanding its claims data requirements for pharmacies dispensing its drugs under the 340B federal drug discount program.
Amgen is expanding its claims data requirements for pharmacies dispensing its drugs under the 340B federal drug discount program.
The company said the new policy …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
FDA floats possible approach to repurpose approved drugs under new uses
Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
More GLP-1 options are coming for federal retirees, but they come with a catch
Fierce Pharma Asia—BMS-Hengrui's $15B deal; Takeda’s 4.5K layoffs; Daiichi’s oncology ambition
CMS to withhold $1.3B in Medicaid funds from California, puts state officials on notice about fraud
BeOne wins FDA approval in lymphoma race
Astellas treatment offers new hope to a devastated rare disease community
Epic, Oracle and Cleveland Clinic among companies to joining CMS prior authorization initiative
To gain tariff exemptions, drugmakers must reveal US production plans
Court approves sale of CVS' Omnicare unit to GenieRx Holdings
